Anaphylaxis Rescue Medication from Multiple manufacturers.
Epinephrine is the first-line treatment for anaphylaxis. Multiple delivery options are available: traditional intramuscular autoinjectors (EpiPen, Auvi-Q, generic epinephrine autoinjector) and intranasal epinephrine (neffy). Selection between options is based on patient preference, insurance coverage, prior experience, and individual clinical considerations. Every patient at risk of anaphylaxis should have an individualized emergency action plan and access to epinephrine at home, at work, and while traveling.
Epinephrine Rescue Options is FDA-approved for the following indications:
Epinephrine autoinjectors are administered intramuscularly into the outer thigh at the first sign of severe allergic reaction. Neffy is administered as a single intranasal spray. After administration of any epinephrine product, patients should call 911 and seek emergency care, as a second dose may be needed and observation is recommended.
The manufacturer offers a patient support program — Manufacturer-specific copay assistance varies by product — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.fda.gov.
Treatment with Epinephrine Rescue Options is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. Patients at risk of severe allergic reactions are prescribed epinephrine and counseled on its use. Selection between autoinjector and intranasal options is individualized based on patient preference, prior experience, insurance coverage, and clinical factors. Every patient receives a written emergency action plan; refills and replacements are coordinated by the office team.
Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.fda.gov) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Epinephrine Rescue Options is appropriate for your situation.
Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine
This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.